Last updated: February 13, 2026
What Is the Market Landscape for NDC 64764-0750?
NDC 64764-0750 is a specific drug identified through the National Drug Code (NDC) system. Precise details about the drug's name, formulation, or therapeutic category are necessary for a detailed market analysis. Without this information, a broad overview based on available patent and market data for similar drugs is provided.
Which Therapeutic Area Does NDC 64764-0750 Cover?
Based on the NDC prefix (64764), the drug is associated with a proprietary or generic pharmaceutical produced by a manufacturer registered within this code range. The suffix (0750) pinpoints the specific formulation. The therapeutic category determines market size, competitive landscape, and pricing.
Assumption: If NDC 64764-0750 is, for example, a biologic or small-molecule drug used in oncology, autoimmune diseases, or infectious diseases, the market dynamics significantly differ.
What Is the Current Market Size for Drugs in This Category?
The global pharmaceutical market was valued at $1.4 trillion in 2022 and is projected to grow at a CAGR of 4-6% until 2030. The subset for niche or specialty drugs, particularly biologics or rare disease treatments, can be more than half of this figure.
For drugs similar to NDC 64764-0750 in the same class:
- The US market size ranges from $500 million to $2 billion annually.
- European and Asian markets contribute an additional $300 million to $2 billion, depending on drug approval status and patent protections.
Market segmentation based on indications, patient population, and payer coverage substantially impacts revenue potential.
What Are the Price Dynamics for Similar Drugs?
Pricing for niche pharmaceuticals varies based on regulatory environment, manufacturing costs, patent status, and competitive landscape.
| Parameter |
Small Molecules |
Biologics |
Biosimilars |
| Average Wholesale Price (AWP) |
$3,000 – $10,000 per year |
$30,000 – $150,000 per year |
$10,000 – $50,000 per year |
| List Price for Treatment Course |
$10,000 – $250,000 |
$50,000 – $1 million |
$20,000 – $150,000 |
New drugs in the same category typically command premium prices compared to existing therapies, especially if they demonstrate improved efficacy or safety profiles.
What Are the Price Projection Trends?
Price trends depend on patent status, biosimilar entry, and reimbursement policies:
- Patent Expiration: Prices generally decrease 20-50% within 1–2 years after patent loss due to biosimilar or generic competition.
- Reimbursement Policies: Value-based pricing models are increasingly adopted, tying prices to clinical outcomes.
- Negotiation Power: Payers leverage discounts, rebates, and formulary placements to control expenses.
How Will Regulatory and Market Factors Influence Pricing?
Regulatory approval, orphan drug status, and pricing regulations significantly impact market access and price points.
- FDA approval: Validates market potential and supports premium pricing.
- Orphan Drug Designation: Allows for market exclusivity up to 7 years in the US, delaying biosimilar competition.
- Price Caps and Negotiations: Countries such as Germany and Canada impose price controls affecting revenue.
What Is the Revenue Forecast for NDC 64764-0750?
Assuming the drug gains approval in its therapeutic niche with a substantial patient population:
| Year |
Revenue Estimate (USD) |
Assumptions |
| 2023 |
$200M - $400M |
Launch year, early market penetration |
| 2025 |
$300M - $600M |
Increasing market share, expansion to Europe |
| 2030 |
$500M - $1B |
Mature market with steady uptake, potential biosimilar competition |
These estimates are highly sensitive to regulatory approvals, patent duration, market acceptance, and pricing strategies.
Final Considerations
- The actual market potential hinges on the drug’s indication, clinical efficacy, safety profile, and patent status.
- Competitive dynamics are shifting as biosimilars enter established biologic markets.
- Payer strategies and state pricing regulations influence real-world pricing and profit margins.
Key Takeaways
- Precise market size and pricing projection depend on the drug's therapeutic area, patent status, and competitive landscape.
- The US and European markets dominate revenue potential, with Asia showing growing interest.
- Price points for similar drugs vary widely, influenced by drug class and regulatory environment.
- Market entry timing and regulatory approvals are critical determinants of revenue trajectories.
- Patent expiration and biosimilar contender entries forecast significant price erosion within 1–2 years post-expiry.
Frequently Asked Questions
1. How does patent status influence drug pricing?
Patent protection maintains exclusivity, allowing the manufacturer to set higher prices. Post-patent expiry, biosimilars or generics enter, driving prices down significantly.
2. What are typical market sizes for niche biologics?
Niche biologics targeting rare diseases or specific indications generally generate between $500 million and $2 billion globally, depending on patient population and approval scope.
3. How do biosimilars impact drug revenues?
Biosimilars introduce competition that can reduce prices by 20-50%, eroding revenue streams over 1–3 years after biosimilar market entry.
4. What regulatory factors most influence drug market access?
FDA or EMA approval, orphan drug status, and national or regional price controls significantly affect market entry and revenue.
5. When should companies consider price adjustments?
Price adjustments are strategic post-patent expiration, during biosimilar competition, or based on value-based pricing agreements with payers.
Citations
[1] IQVIA, "The Global Use of Medicine in 2022," IQVIA Institute for Human Data Science.
[2] EvaluatePharma, "World Preview 2023," When to Expect Market Changes.
[3] FDA, "Guidance for Industry: Biosimilar Development," 2020.
[4] European Medicines Agency, "Market Access and Pricing," 2022.
